The immunopharmacology of skin inflammation: the future is already here!
- 1 July 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 143 (1) , 47-52
- https://doi.org/10.1046/j.1365-2133.2000.03588.x
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Inflammatory Skin Diseases, T Cells, and Immune SurveillanceNew England Journal of Medicine, 1999
- Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.Journal of Clinical Investigation, 1998
- Targetting IgE with monoclonal antibodies: the future is nowClinical and Experimental Allergy, 1998
- Intravenous immunoglobulin in autoimmune chronic urticariaBritish Journal of Dermatology, 1998
- IL-10: a potential therapy for allergic inflammation?Immunology Today, 1997
- Dermal Mast Cell Activation by Autoantibodies Against the High Affinity IgE Receptor in Chronic UrticariaJournal of Investigative Dermatology, 1996
- Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils.The Journal of Experimental Medicine, 1996
- Biology of interleukin‐5 and its relevance to allergic diseaseAllergy, 1996
- Autoimmune disease. a problem of defective apoptosisArthritis & Rheumatism, 1994
- Plasmapheresis for severe, unremitting, chronic urticariaPublished by Elsevier ,1992